CYP19A1 and Hyperglycemia: Thus, in male mice with global loss of aromatase activity, overt hyperglycemia was seen by 3 months of age in association with increased expression of gluconeogenic genes in liver and, subsequently, increased hepatic triglyceride accumulation [33].